Preferential Modulatory Action of 5-HT2A Receptors on the Dynamic Regulation of Basal Ganglia Circuits

Article Information

DOI

PubMed

Published By

History

¹Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain
²Université de Bordeaux, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France
³Institut des Maladies Neurodégénératives, CNRS UMR 5293, Université de Bordeaux 33076 Bordeaux, France
⁴Neurodegenerative Diseases Group, Biocruces Health Research Institute, 48903 Barakaldo, Spain

Author contributions: L.U. and T.M.-H. designed research; L.G., A.G.-C., M.A., and N.P.M. performed research; L.G., A.G.-C., M.A., and T.M.-H. analyzed data; L.U. and T.M.-H. wrote the paper.

This study was supported by the University of the Basque Country (Grant GIU19/092), the Basque Government (Grant IT1706-22), and the Ministry of Economy and Competitiveness of Spain (Grant SAF2016-77758-R, Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional, European Union). This research was conducted in the scope of the Transborder Joint Laboratory (LTC) “non-motor comorbidities in Parkinson's disease (CoMorPD).” L.G. has a fellowship from the University of the Basque Country. M.A. had a fellowship from the MECD. We thank Raphaelle Bidgood for language editing assistance and comments on the manuscript.
The authors declare no competing financial interests.
Correspondence should be addressed to Teresa Morera-Herreras at teresa.morera{at}ehu.eus

Euskal Herriko Unibertsitatea (EHU)
GIU19/092
Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (MINECO)
SAF2016-77758-R
Basque Government
IT1706-22